4th Masterclass in Clinical Oncology
30 ESCO credits
18.10.2017 - 20.10.2017
Tbilisi, Gerogia
MASTERCLASS
Description
Chairs: N. Pavlidis, GR - D.G. Zaridze, RU
Host Chair: R. Gvamichava, GE
AIMS AND OBJECTIVES
This clinically oriented educational programme has been designed for medical and clinical oncologists who wish to improve their skills in the management of cancer patients.
The programme will expose participants to a full spectrum of issues in clinical oncology and to practice-orientated training. The programme focuses on lung, head and neck, gynaecological, genito-urinary, breast, and colorectal cancers. Spotlight sessions will facilitate compact update on melanoma, cervical cancer and pregnancy.
TEACHING FORMAT
The Masterclass offers plenary lectures discussing current issues and controversies as well is critically reviewing significant therapeutic developments. State-of-the-art data recognized by ESMO and other evidence-based guidelines will be cited. Participants will deliver case presentations within tumour boards and discuss them with the chairs and the faculty.
All participants will reside at the course venue and participation is compulsory throughout the course. The Masterclass will be entirely in English and at least an intermediate level of English is necessary for admission.
THE MASTERCLASS IS:
• Full immersion
• Clinically-oriented
• Multidisciplinary
• An international faculty of top experts delivering lectures focusing on lung, head and neck, gynaecological, genito-urinary and breast cancers.
General information
ORGANISING SECRETARIAT
Daniela Mengato
European School of Oncology
Via Turati, 29 | 20121 Milan | Italy
Tel: +39 02 85464523 | Fax: +39 02 85464545
Email: dmengato@eso.net
APPLICATIONS
Alice Ciocchini
Ph: +39 02 85464529
Email: eurasia@eso.net
Faculty list
FACULTY
G.L. Ceresoli, Istituto Humanitas Gavazzeni, Bergamo, IT
F. Geara, American University of Beirut, LB
J. Gligorov, APHP Tenon, IUC-UPMC, Sorbonne University, Paris, FR
R. Gvamichava, Georgian National Cancer Center, Tbilisi, GE
M. Halaska, Charles University, Prague, CZ
B. Jereczek Fossa, European Institute of Oncology, Milan, IT
O. Pagani, Oncology Institute of Southern Switzerland (IOSI), Bellinzona, CH
N. Pavlidis, University Hospital of Ioannina, GR
E. Senkus, Medical University of Gdansk, PL
A. Shamseddine, American University of Beirut, LB
J. Souglakos, University Hospital of Heraklion, GR
P. Van Houtte, Institut Jules Bordet, Brussels, BE
J.B. Vermorken, Antwerp University Hospital, Edegem, BE
D.G. Zaridze, N.N. Blokhin Cancer Research Center, Moscow, RU
Programme
18 OCTOBER
| 8:30 | Welcome address and general introduction R. Gvamichava, GE - N. Pavlidis, GR - D.G. Zaridze, RU | |
HEAD AND NECK | ||
9:90 | Radiotherapy of head and neck cancer | |
9:30 | Systemic treatment in head and neck cancer J.B. Vermorken, BE | |
| 10:00 | Spotlight: Advances of systemic treatment in metastatic colorectal cancer J. Souglakos, GR | |
| 10:30 | Coffee break | |
| 11:00- 13:00 | Tumour board | |
| 13:00 | Lunch | |
| LUNG CANCER Chairs: P. Van Houtte, BE | ||
| 14:00 | Radiotherapy of lung cancer P. Van Houtte, BE | |
| 14:30 | Neoadjuvant and adjuvant treatment in NSCLC G.L. Ceresoli, IT | |
| 15:00 | Systemic treatment in advanced NSCLC G.L. Ceresoli, IT | |
| 15:30 | Treatment of small cell lung cancer V. Gorbunova, RU | |
| 16:00 | Coffee break | |
16:30- | Tumour board | |
| 20:00 | Dinner | |
19 OCTOBER
| GENITOURINARY CANCERS Chair: A. Shamseddine, LB | ||
| 9:00 | Local therapy of prostate cancer P. Van Houtte, BE | |
9:30 | First line treatment in hormone sensitive advanced prostate cancer | |
| 10:00 | Endocrine resistant/refractory prostate cancer | |
10:30 | Coffee break | |
11:00 | Management of advanced metastatic renal cancer G.L. Ceresoli, IT | |
11:30 | Tumour board | |
13:30 | Lunch break | |
| GYNAECOLOGICAL CANCERS Chairs: J.B. Vermorken, BE | ||
14:30 | Radiotherapy of cervical and endometrial cancers | |
15:00 | Systemic treatment of ovarian cancer J.B. Vermorken, BE | |
| 15:30 | Systemic treatment of cervical and endometrial cancers J.B. Vermorken, BE | |
| 16:00 | Coffee break | |
| 16:30 | Spotlight: Cervical cancer and pregnancy | |
| 17:00 | Tumour board | |
| 20:00 | Dinner | |
20 OCTOBER
BREAST CANCER | ||
9:00 | Radiotherapy of breast cancer | |
| 9:30 | Neoadjuvant and adjuvant chemotherapy and biological agents J. Gligorov, FR | |
10:00 | Neoadjuvant and adjuvant endocrine therapy | |
| 10:30 | Treatment of HER-2 positive advanced breast cancer E. Senkus, PL | |
11:00 | Coffee break | |
| 11:30 | Treatment of triple negative advanced breast cancer J. Gligorov, FR | |
| 12:00 | Treatment of ER positive advanced breast cancer E. Senkus, PL | |
| 12:30 | Management of breast cancer in young women O. Pagani, CH | |
| 13:00 | Lunch break | |
14:30 | Tumour board | |
17:00 | Coffee break | |
| 17:30- 18:30 | Participants’ self-assessment test | |